G-BA Innovation Committee announced funding of 52 new projects in Germany

14

Sep 2021

In late August 2021, the Innovation Committee at the Federal Joint Committee (G-BA) has announced funding d of 52 innovative projects on health care research from the G-BA Innovation Fun.

In this cycle, 269 applications were received, and the selection was made based on the recommendations from the pool of experts and the Working Group of Scientific Medical Societies (AWMF). There are positive funding decisions for four project applications from the open-topic area and for 48 project applications from the topic-specific area, which are divided into the following way:

  • Rare disease care: 11 (medical guidelines)
  • Care of people with mental illnesses and needs of complex treatment: 8 (medical guidelines)
  • Prevention and treatment of infectious diseases, specifically to strengthen appropriate antibiotic therapy and to contain antimicrobial resistance: 4 (medical guidelines)
  • Health services research on findings in dealing with pandemics: 2
  • Patient journey in health care: 7
  • Cross-sector and outpatient patient-reported outcome measures (PROMs) / patient-reported experience measures (PREMs): 5
  • Geriatric medicine: 3
  • Reducing the complexity of administrative tasks in health care: 1
  • Prevention strengthening: 5
  • Use and reliability of artificial intelligence applications in health care: 2

The overview of the new projects is expected to be published on the Innovation Committee's website in September 2021.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

09

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more